Gene · 9002
Papers2,206
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,206
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interfering with CSE1L/CAS inhibits tumour growth via C3 in triple-negative breast cancer. | Cell Prolif | 2022 | 35403306 | PubTator, text mining | PubMed |
| Recent advance in treatment of atherosclerosis: Key targets and plaque-positioned delivery strategies. | J Tissue Eng | 2022 | 35356091 | PubTator, text mining | PubMed |
| An optimized agonist peptide of protease-activated receptor 4 and its use in a validated platelet-aggregation assay. | Platelets | 2022 | 35343875 | PubTator, text mining | PubMed |
| Ethical implications of epigenetics in the era of personalized medicine. | Clin Epigenetics | 2022 | 35337378 | PubTator, text mining | PubMed |
| α2-Antiplasmin as a Potential Therapeutic Target for Systemic Sclerosis. | Life (Basel) | 2022 | 35330147 | PubTator, text mining | PubMed |
| Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches. | Int J Mol Sci | 2022 | 35328719 | PubTator, text mining | PubMed |
| Components of the Lectin Pathway of Complement in Solid Tumour Cancers. | Cancers (Basel) | 2022 | 35326694 | PubTator, text mining | PubMed |
| Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer's disease? | Ther Adv Chronic Dis | 2022 | 35321401 | PubTator, text mining | PubMed |
| The Specific Role of Reactive Astrocytes in Stroke. | Front Cell Neurosci | 2022 | 35321205 | PubTator, text mining | PubMed |
| The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets. | Kidney Int Suppl (2011) | 2022 | 35316977 | PubTator, text mining | PubMed |
| Early life affects late-life health through determining DNA methylation across the lifespan: A twin study. | EBioMedicine | 2022 | 35301182 | PubTator, text mining | PubMed |
| Specific inhibition of the transporter MRP4/ABCC4 affects multiple signaling pathways and thrombus formation in human platelets. | Haematologica | 2022 | 35295075 | PubTator, text mining | PubMed |
| Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis. | Platelets | 2022 | 35294323 | PubTator, text mining | PubMed |
| Platelet-released extracellular vesicles: the effects of thrombin activation. | Cell Mol Life Sci | 2022 | 35288766 | PubTator, text mining | PubMed |
| 3,5,2',4'-Tetramethoxystilbene, a fully methylated resveratrol analog, prevents platelet aggregation and thrombus formation by targeting the protease-activated receptor 4 pathway. | Chem Biol Interact | 2022 | 35288162 | PubTator, text mining | PubMed |
| Analysis of the long non-coding RNA and mRNA expression profiles associated with lidocaine-induced neurotoxicity in the spinal cord of a rat model. | Neurotoxicology | 2022 | 35283115 | PubTator, text mining | PubMed |
| Role of Complement System in Kidney Transplantation: Stepping From Animal Models to Clinical Application. | Front Immunol | 2022 | 35281019 | PubTator, text mining | PubMed |
| Epigenome-wide association study and epigenetic age acceleration associated with cigarette smoking among Costa Rican adults. | Sci Rep | 2022 | 35277542 | PubTator, text mining | PubMed |
| Piezo1 activation attenuates thrombin-induced blebbing in breast cancer cells. | J Cell Sci | 2022 | 35274124 | PubTator, text mining | PubMed |
| Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and Progression. | Int J Mol Sci | 2022 | 35269825 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9002/papers?page=20